Jim Simons Sera Prognostics, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$5.6 - $11.69 $153,440 - $320,306	27,400 New	27,400 $162,000
Q4 2022 Feb 13, 2023	SELL	$1.16 - $1.8 $47,490 - $73,692	-40,940 Reduced 60.8%	26,400 $33,000
Q3 2022 Nov 14, 2022	SELL	$1.55 - $2.71 $64,532 - $112,828	-41,634 Reduced 38.21%	67,340 $108,000
Q2 2022 Aug 12, 2022	BUY	$1.2 - $3.62 $130,768 - $394,485	108,974 New	108,974 $179,000

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $241M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.